Antipsychotic-induced rabbit syndrome: Epidemiology, management and pathophysiology

CNS Drugs

Volumn 18, Issue 4, 2004, Pages 213-220

  Schwartz, Miguel ^a   Hocherman, Shraga ^b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMANTADINE; ANTIPARKINSON AGENT; ATROPINE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DIAZEPAM; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; PROCYCLIDINE; RISPERIDONE; SULPIRIDE; TIAPRIDE; TRIHEXYPHENIDYL; TRYPTOPHAN;

ANAMNESIS; BASAL GANGLION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSKINESIA; HUMAN; INVOLUNTARY MOVEMENT; LIP; MASTICATION; MOUTH; MOUTH CAVITY; MOUTH DYSKINESIA; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; PARASYMPATHETIC INNERVATION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RABBIT; RABBIT SYNDROME; REVIEW; SEIZURE; STEREOTYPY; SUBSTANTIA NIGRA; SYNDROME DELINEATION; TARDIVE DYSKINESIA; TONGUE; TREATMENT WITHDRAWAL;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; DYSKINESIA, DRUG-INDUCED; HUMANS; RABBITS; RISPERIDONE;

EID: 1642364505     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200418040-00002     Document Type: Review

References (39)

1. Villeneuve A. The rabbit syndrome: a peculiar extrapyramidal reaction. Can Psychiatr Assoc J 1972; 17 Suppl. 2: SS69
2. Schwartz M, Weller B, Erdreich M, et al. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment [letter]. J Clin Psychiatry 1995; 56: 212
3. Jus K, Villeneuve A, Jus A. Tardive dyskinesia and the rabbit syndrome during wakefulness and sleep [letter]. Am J Psychiatry 1972; 129; 765
4. Miwa H, Sassaki Y, Hatori K, et al. Idiopathic rabbit syndrome: a case report. No To Shinkei 1999; 10: 907-9
5. Nishiyama K, Masuda N, Kurisaki H. A case of rabbit syndrome: its unique pharmacological feature. Rinsho Shinkeigaku 1993; 33: 663-5
6. Kamijo Y, Soma K, Fukuda M, et al. Rabbit syndrome following phenol ingestion. J Toxicol Clin Toxicol 1999; 37: 509-11
7. Todd R, Lippmann S, Manshadi M, et al. Recognition and treatment of rabbit syndrome, an uncommon complication of neuroleptic therapies. Am J Psychiatry 1983; 140: 1519-20
8. Sethi S. Rabbit syndrome: an acute complication of neuroleptic medication. Indian J Psychiatry 2001; 43: 3
9. Schwartz M, Beny A, Sharf B. Risperidone-induced rabbit syndrome. Br J Psychiatry 1998; 173: 267-8
10. Levin T, Heresco-Levy U. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic. Eur Neuropsychopharmacol 1999; 9: 137-9
11. Hoy JS, Alexander B. Rabbit syndrome secondary to risperidone. Pharmacotherapy 2002; 22: 513-5
12. Nishimura K, Tsuka M, Horikawa N. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone. Eur Neuropsychopharmacol 2001; 11: 323-4
13. Sethi S, Bhargava SC. Clozapine-induced rabbit syndrome. J Clin Psychiatry 2003; 64 (2): 219
14. Fornazzari L, Ichise M, Remington G, et al. Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings. J Psychiatry Neurosci 1991; 16: 227-9
15. Damodaran SS, Thankamma JK. Reversal of rabbit syndrome with olanzapine. Aust N Z J Psychiatry 2000; 34: 172-3
16. Deshmukh DK, Joshi VS, Agarwal MR. Rabbit syndrome: a rare complication of long-term neuroleptic medication. Br J Psychiatry 1990; 157: 293
17. Durst R, Katz G, Zislin J, et al. Rabbit syndrome treated with olanzapine [letter]. Br J Psychiatry 2000; 176: 193
18. Inada T, Yagi G, Kaijima K, et al. Clinical variants of tardive dyskinesia in Japan. Jpn J Psychiatry Neurol 1991; 45: 67-71
19. Kakigi R, Kuroda Y, Shibasaki H. The rabbit syndrome induced by sulpiride: a case report. Rinsho Shinkeigaku 1982; 22: 557-62
20. Sovner R, Dimascio A. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia. Am J Psychiatry 1977; 134: 1301-2
21. Wada Y, Yamaguchi N. The rabbit syndrome and antiparkinsonian medication in schizophrenic patients. Neuropsychobiology 1992; 25: 149-52
22. Weiss KJ, Ciraulo DA, Shader RI. Physostigmine test in the rabbit syndrome and tardive dyskinesia. Am J Psychiatry 1980; 137: 627-8
23. Yassa R, Samarthji L. Prevalence of rabbit syndrome. Am J Psychiatry 1986; 143: 656-7
24. Casey DE. Rabbit syndrome. In: Joseph AB, Young RR, editors. Movement disorders in neurology and neuropsychiatry. London: Blackwell Scientific Publications, 1992: 139-42
25. Nambu A, Tokuno H, Takada M. Functional significance of the cortico/subthalamo/pallidal 'hyperdirectic' pathway. Neurosci Res 2002; 43: 111-7
26. Calabresi P, Centonze D, Gubellini P, et al. Acetylcholine-mediated modulation of striatal function. Trends Neurosci 2000; 23: 120-6
27. Kaneko S, Hikida T, Watanabe D, et al. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 2000; 289: 633-7
28. Di-Chiara G, Morelli M, Consolo S. Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions. Trends Neurosci 1994; 17: 228-33
29. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13: 266-71
30. Smith Y, Bevan MD, Shink E, et al. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998; 86: 353-87
31. Lang AE, Lozano AM. Parkinson's disease: second of two parts. N Engl J Med 1998; 339: 1130-43
32. Onn SP, West AR, Grace AA. Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci 2000; 23 (10 Suppl.): S48-56
33. Parent A, Sato F, Wu Y, et al. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 2000; 23 (10 Suppl.): S20-7
34. Hazrati LN, Parent A. The striatopallidal projection displays a high degree of anatomical specificity in the primate. Brain Res 1992; 592: 213-27
35. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000; 31: 236-50
36. Canales JJ, Gilmour G, Iversen SV. The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum. Brain Res 2000; 856: 176-83
37. Aosaki T, Kimura M, Graybiel AM. Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J Neurophysiol 1995; 73: 1234-52
38. Zhou F-M, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 2001; 4: 1224-9
39. Calabresi P, Pisani A, Mercuri NB, et al. The corticostriatal projection from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 1996; 19: 19-24